Displaying drugs 1801 - 1825 of 2774 in total
| Name | Weight | Structure | Description | Categories |
|---|---|---|---|---|
| Dexchlorpheniramine maleate | 390.86 C20H23ClN2O4 |  | A first generation antihistamine used to treat allergic and vasomotor rhinitis, allergic conjunctivitis, and mild urticaria and angioedema. | Histamine H1 Antagonists / Stereoisomerism |
| Meclizine | 390.948 C25H27ClN2 |  | A histamine H1 antagonist used to treat nausea, vomiting, and dizziness associated with motion sickness. | Piperazine Derivatives |
| Permethrin | 391.288 C21H20Cl2O3 |  | An insecticide used to prevent infestation with Sarcoptes scabiei (scabies). | Pyrethrines, Incl. Synthetic Compounds |
| Flavoxate | 391.4596 C24H25NO4 |  | A muscarinic antagonist and spasmolytic used for the symptomatic relief of conditions associated with lack of muscle control in the bladder, such as dysuria, urgency, and nocturia. | Drugs for Urinary Frequency and Incontinence |
| Ethylhexyl methoxycrylene | 391.511 C25H29NO3 |  | Ethylhexyl methoxycrylene is employed as a photostabilizing agent in various sunscreen products . | Not Available |
| Dimetotiazine | 391.55 C19H25N3O2S2 |  | Dimetotiazine has considerable antiemetic & serotonin antagonistic action used mainly in allergic skin conditions. | Histamine H1 Antagonists |
| Aurothioglucose | 392.18 C6H11AuO5S |  | A gold compound used in the treatment of rheumatoid arthritis. | Gold Preparations |
| Sparfloxacin | 392.3998 C19H22F2N4O3 |  | A fluoroquinolone antibiotic used to treat bacterial respiratory infections and sinusitis. | Anti-Bacterial Agents / Fluoroquinolones |
| Betamethasone | 392.4611 C22H29FO5 |  | A systemic corticosteroid used to relieve inflammation in various conditions, including but not limited to allergic states, dermatologic disorders, gastrointestinal diseases, and hematological disorders. | Corticosteroids Acting Locally / Corticosteroids, Potent (Group III) / Glucocorticoids |
| Dexamethasone | 392.4611 C22H29FO5 |  | A glucocorticoid available in various modes of administration that is used for the treatment of various inflammatory conditions, including bronchial asthma, as well as endocrine and rheumatic disorders. | Corticosteroids for Local Oral Treatment / Corticosteroids, Moderately Potent (Group II) |
| Ivacaftor | 392.4907 C24H28N2O3 |  | A cystic fibrosis transmembrane conductance regulator (CFTR) potentiator used alone or in combination products to treat cystic fibrosis in patients who have specific genetic mutations that are responsive to the medication. | Chloride Channel Agonists / Cystic Fibrosis Transmembrane Conductance Regulator Potentiators |
| Indacaterol | 392.4907 C24H28N2O3 |  | An inhaled long-acting beta-2 adrenergic agonist used to relax bronchial smooth muscle and improve symptoms and airflow obstruction caused by Chronic Obstructive Pulmonary Disease (COPD) and moderate to severe asthma. | Agents producing tachycardia / Agents that produce hypertension |
| Tiotropium | 392.512 C19H22NO4S2 |  | A long-acting bronchodilator used in the management of chronic obstructive pulmonary disease (COPD). | Agents producing tachycardia |
| Trospium | 392.518 C25H30NO3 |  | An antimuscarinic agent used to treat the symptoms of overactive bladder (OAB). | Drugs for Urinary Frequency and Incontinence |
| Deoxycholic acid | 392.572 C24H40O4 |  | A cytolytic agent injected subcutaneously to improve the appearance submental fat. | Cholagogues and Choleretics / Cholic Acids / Cytolytic Agent |
| Ursodeoxycholic acid | 392.572 C24H40O4 |  | A bile acid used for the treatment of primary biliary cirrhosis (PBC). | Bile Acid Preparations / Bile acids and derivatives |
| Chenodeoxycholic acid | 392.572 C24H40O4 |  | A bile acid used for the treatment of primary biliary cirrhosis. | Bile Acid Preparations / Bile acids and derivatives |
| Pentetic acid | 393.349 C14H23N3O10 |  | DTPA is widely used in industry and medicine. As a medical agent, it is approved for its use in medical imaging and for the decorporation of internally deposited radionuclides. It... | Acetates / Antidotes / Chelating Agents / Iron Chelating Agents / Lead Chelator / Polyamines |
| Fruquintinib | 393.399 C21H19N3O5 |  | A VEGF receptor inhibitor used to treat metastatic colorectal cancer. | Cytochrome P-450 CYP2C19 Substrates / Cytochrome P-450 CYP2C8 Substrates / Cytochrome P-450 CYP2C9 Substrates / Cytochrome P-450 CYP3A Substrates / Cytochrome P-450 CYP3A4 Substrates / Cytochrome P-450 CYP3A5 Substrates / Cytochrome P-450 CYP3A7 Substrates / Cytochrome P-450 Substrates / Heterocyclic Compounds, Fused-Ring |
| Erlotinib | 393.4357 C22H23N3O4 |  | An EGFR tyrosine kinase inhibitor used to treat certain small cell lung cancers or advanced metastatic pancreatic cancers. | Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors / Protein Kinase Inhibitors |
| Daprodustat | 393.44 C19H27N3O6 |  | A small-molecule hypoxia-inducible factor prolyl hydroxylase inhibitor used for the treatment of anemia in patients with chronic kidney disease. | Amino Acids / Amino Acids, Peptides, and Proteins / Antianemic Preparations / BCRP/ABCG2 Substrates / Blood and Blood Forming Organs / Cytochrome P-450 CYP2C8 Inhibitors / Cytochrome P-450 CYP2C8 Inhibitors (strength unknown) / Cytochrome P-450 CYP2C8 Substrates / Cytochrome P-450 CYP3A Substrates / Cytochrome P-450 CYP3A4 Substrates / Cytochrome P-450 Enzyme Inhibitors / Cytochrome P-450 Substrates / Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor / Hypoxia-Inducible Factor-Proline Dioxygenases, antagonists & inhibitors / OAT1/SLC22A6 Substrates / OAT3/SLC22A8 Substrates / OATP1B1/SLCO1B1 Inhibitors / OATP1B3 inhibitors / Pyrimidines / Pyrimidinones |
| Amsacrine | 393.459 C21H19N3O3S |  | A cytotoxic agent used to induce remission in acute adult leukemia that is not adequately responsive to other agents. | Aminoacridines / Intercalating Agents |
| Lumateperone | 393.506 C24H28FN3O |  | A novel 2nd generation antipsychotic used to manage both positive and negative symptoms in patients with schizophrenia. | Butyrophenone Derivatives |
| Iodoform | 393.732 CHI3 |  | No approved therapeutic indications. | Medicated Dressings With Antiinfectives |
| Besifloxacin | 393.84 C19H21ClFN3O3 |  | A fluoroquinolone antibiotic agent used for the treatment of bacterial conjunctivitis. | Fluoroquinolones |
Displaying drugs 1801 - 1825 of 2774 in total